RIPK3-deficient mice have been reported by us and others to be partially protected from SIRS induced by intravenous injection of recombinant TNFα15,16, but it remained unclear which downstream RIPK3 target mediates this protection. This evidence concerns the gene RIPK3 and systemic inflammatory response syndrome.